BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04209855-completion@plaintrial.com
DTSTAMP:20261028T004220Z
DTSTART;VALUE=DATE:20241029
SUMMARY:A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC)
  of Chemotherapy in Platinum-Resistant\, Advanced High-Grade Epithelial Ov
 arian\, Primary Peritoneal\, or Fallopian Tube Cancers With High Folate Re
 ceptor-Alpha (FRα) Expression — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04209855
URL:https://plaintrial.com/trial/NCT04209855
END:VEVENT
END:VCALENDAR